"It would be great if Rubraca works as maintenance therapy for patients with BRCA-associated pancreatic cancer," she said. "It would free some patients from the need for lifelong chemo."
from Forbes Real Time https://www.forbes.com/sites/elaineschattner/2017/09/11/rubraca-a-parp-inhibitor-active-in-ovarian-cancer-might-control-pancreatic-cancer-even-if-it-doesnt-cure/
via IFTTT
No comments:
Post a Comment